News

At ASRS 2025 in Long Beach, Dilsher Dhoot, MD, of California Retina Consultants presented promising preclinical data on avoralstat, a plasma kallikrein inhibitor being explored as a novel treatment ...
Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
Opus Genetics partners with the Global RDH12 Alliance to advance gene therapy for inherited retinal disease, aiming for FDA application by late 2025.
Yasha S. Modi, MD, discusses promising results from the VERONA study on EYP-1901, a potential treatment for diabetic macular edema.
The 2025 meeting of the American Society of Retina Specialists (ASRS) meeting is taking place in Long Beach, California. At this event, Veeral S. Sheth, MD, MBA, FASRS, FACS, gave a presentation ...
Grupcheva is head of the Department of Ophthalmology and Visual Sciences and vice rector at the Medical University of Varna. She represents Bulgaria and is also currently president elect of the ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Tadayoni is professor of ophthalmology at Université de Paris in France and head of department at Lariboisière, Saint Louis and Adolphe de Rothschild Foundation hospitals. He is a European Society of ...